Nanalysis Scientific (TSE:NSCI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nanalysis Scientific Corp. and the United States Pharmacopeia have co-published a study demonstrating the effectiveness of benchtop NMR technology for quality control in pharmaceuticals. The study highlights the advantages of this portable NMR solution, including faster measurements and reduced solvent usage, making it an accessible and scalable option for the industry. This advancement positions Nanalysis Scientific to potentially drive growth in pharmaceutical quality assurance globally.
For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue